Analysis of Blood Banking Technologies And Strategic Profiles of Leading Suppliers

September 2012 | 114 pages | ID: A890EFFFCFCEN
Venture Planning Group

Abstracts

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.

The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 114 pages

Contents

CURRENT AND EMERGING TECHNOLOGIES

MOLECULAR DIAGNOSTICS

a. Overview
b. NAT

MONOCLONAL AND POLYCLONAL ANTIBODIES

IMMUNOASSAYS

a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography

MICROTITRATION PLATES

IT AND AUTOMATION

LASERS

ROBOTICS

SYNTHETIC RED CELL SUBSTITUTES

GENETICALLY ENGINEERED BLOOD COMPONENTS

a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA

BLOOD PRESERVATION

AUTOLOGOUS BLOOD TRANSFUSION/FREEZING

COMPETITIVE PROFILES

    Abbott
    Beckman Coulter/Danaher
    Becton Dickinson
    Biokit
    BioMerieux
    Bio-Rad
    Diagast
    DiaSorin
    Fujirebio
    Gen-Probe
    Grifols
    Immucor
    Innogenetics
    Ortho-Clinical Diagnostics
    Orchid CellMark
    Novartis Diagnostics
    Proteome Sciences
    Roche
    Siemens
    Tecan